AI Analysis AI Analysis of NPCE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NPCE to Watchlist?
Some Reasons Why To Add NPCE:
  • High gross margin of 78.3%
  • Bullish trend confirmed on both short and long timeframes
  • Highly efficient cash conversion (104% FCF/OCF ratio)
PDF

NeuroPace, Inc. stock price ended at $15.37 on Monday, after losing 1.66%
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 01, 2026 Loss -6.90%

The NeuroPace, Inc. stock price fell by -1.66% on the last day (Monday, 22nd Jun 2026) from $15.63 to $15.37. During the last trading day the stock fluctuated 3.93% from a day low at $15.27 to a day high of $15.87. The price has fallen in 6 of the last 10 days and is down by -2.35% for this period. Volume has increased on the last day by 75 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 201 thousand shares were bought and sold for approximately $3.08 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $14.69 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.05% during the next 3 months and, with a 90% probability hold a price between $16.32 and $22.50 at the end of this 3-month period.

NPCE Signals & Forecast

There are few to no technical positive signals at the moment. The NeuroPace, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.43 and $16.29. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 07, 2026, and so far it has fallen -20.32%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for NeuroPace, Inc. stock

NeuroPace, Inc. finds support from accumulated volume at $14.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.600 between high and low, or 3.93%. For the last week, the stock has had daily average volatility of 4.59%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NPCE) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect NeuroPace, Inc. to open at $15.50, and during the day (based on 14 day Average True Range), to move between $14.98 and $15.76, which gives a possible trading interval of +/-$0.771 (+/-5.15%) up or down from last closing price. If NeuroPace, Inc. takes out the full calculated possible swing range there will be an estimated 5.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.67 (1.95%) than the support at $14.65 (4.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NeuroPace, Inc. stock A Buy?

The NeuroPace, Inc. stock holds several negative signals and despite the positive trend, we believe NeuroPace, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.895 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $15.50 ( 0.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NPCE Performance

Trading levels for NPCE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 16.10 4.77%
R2 15.87 3.28%
R1 15.73 2.36%
Price 15.37
S1 15.27 -0.624%
S2 15.13 -1.55%
S3 14.90 -3.04%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.54 7.61%
R2 15.81 2.86%
R1 15.67 1.95%
Price 15.37
S1 14.65 -4.68%
S2 13.53 -11.97%
S3 13.15 -14.44%

FAQ

What is the symbol for NeuroPace, Inc. Stock and on which exchange is it traded?
The symbol for NeuroPace, Inc. is NPCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroPace, Inc. Stock?
The NeuroPace, Inc. stock holds several negative signals and despite the positive trend, we believe NeuroPace, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy NeuroPace, Inc. Stock?
NeuroPace, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroPace, Inc. Stock.

What's the current price of NeuroPace, Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an NeuroPace, Inc. (NPCE) share was $15.37.

What is the 52-week high and low for NeuroPace, Inc. Stock?
The 52-week high for NeuroPace, Inc. Stock is $19.60 and the 52-week low is $7.56.

What is the market capitalization of NeuroPace, Inc. Stock?
As of the Jun 22, 2026, the market capitalization of NeuroPace, Inc. is 524.021M.

When is the next earnings date for NeuroPace, Inc.?
The upcoming earnings date for NeuroPace, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT NEUROPACE, INC.
NeuroPace
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE